Product Description: NLRP3-IN-37 (Compound 23) is a NLRP3 inhibitor (EC50: 5 nM). NLRP3-IN-37 can be used for NLRP3 related research, such as gout, pseudogout, CAPS, NASH fibrosis, heart failure, idiophathic pericarditis, atopic dermatitis, inflammatory bowel disease, Alzheimer's Disease, Parkinson's Disease and traumatic brain injury[1].
Formula: C22H22F3N5O
References: [1]Donna A. A, et al. WPhthalazine derivatives useful as inhibitors of nod-like receptor protein 3. Patent.WO2024064245A1.
CAS Number: 3033054-51-9
Molecular Weight: 429.44
Research Area: Inflammation/Immunology; Neurological Disease
Solubility: 10 mM in DMSO
Target: NOD-like Receptor (NLR)